EFFECTIVENESS OF SIBERIAN FIR EXTRACT USED AS AN INTERFERON INDUCTOR IN COMPLEX THERAPY OF ACUTE RESPIRATORY VIRAL INFECTIONS

Author:

Burkova V.N.1,Sergun V.P.1,Ivanov A.A.1

Affiliation:

1. "Biolit" LLC, Academichesky Ave., 4 building 3, Tomsk, 634055, Russian Federation

Abstract

Objective is a study of the effectiveness and safety of using a "Florenta" dietary supplement based on Siberian fir extract as an interferon inducer in the complex therapy of acute respiratory viral infections. Material and methods. The object of the study was a biologically active food supplement based on a concentrated aqueous extract of Siberian fir needles (Abies sibirica L.). The patients under observation were adults with various manifestations of acute respiratory viral infection (ARVI). The pa-tients were matched in age, gender and concomitant pathology. During the study, vital signs were monitored and tolerability and possible adverse events were recorded. The results of laboratory parameters were as-sessed and an overall evaluation of the effectiveness of therapy and patient satisfaction with treatment results was made. Results. It has been established that the Siberian fir extract included into the treatment of patients with mild to moderate ARVI allows managing the clinical symptoms of the disease in a shorter time and increasing the effectiveness of complex therapy. At the same time, the risk of complications is reduced and the prognosis for the disease course becomes positive. The drug under study has been proven to be well tolerated and safe. Analysis of interferon status has revealed a significant improvement in the parameters of interferons under study. Conclusions. As a result of the studies, it has been found out that a biologically active food supplement based on Siberian fir extract as part of com-plex therapy for ARVI reduces the severity and intensity of symptoms of the disease, accelerates the recovery of patients and leads to the normaliza-tion of their interferon status

Publisher

Russian Vrach, Publishing House Ltd.

Reference11 articles.

1. Svistushkin V.M., Mustafaev D.M. Ostrye respiratornye virusnye infekcii: principy racional'noj terapii. RMZh. 2014; 26: 1897–1902.

2. Ayittey F.K., Ayittey M.K., Chiwero N.B., et al. Economic impacts of Wuhan 2019-nCoV on China and the world. J. Med. Virol. 2020; 92(5): 473–475.

3. Ershov F.I., Narovljanskij A.N. Problema primenenija interferonov pri novoj koronavirusnoj infekcii COVID-19 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus). Voprosy virusologii. 2022; 67(2). 115–125.

4. Vavilenkova Ju.A. Sovremennye predstavlenija o sisteme interferona. Vestnik Smolenskoj gosudarstvennoj medicinskoj akademii. 2012; 2: 74–82.

5. Rafal'skij V.V. Klinicheskoe primenenie preparatov interferona. Smolensk: Rusich-Print. 1997. 234 s.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3